ARCT
Arcturus Therapeutics Holdings Inc.
NASDAQ · Healthcare · Biotechnology · US
$15.82
+1.67%Margins
Gross margin
83.2%
EBITDA margin
-348.4%
EBIT margin
-433.4%
Net margin
-391.9%
FCF margin
-306.9%
-54.3%
Return on equity
-41.6%
Return on assets
-53.0%
Return on invested capital
0.10x
Asset turnover
-$72.7M
Cash from operations
$6.74
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026